Introduction
Recurrent pregnancy loss (RPL) is one of the most common complications of pregnancy that is defined as two or more consecutive miscarriages occurring one in every 300 pregnancies (1, 2). One possible cause of RPL is impaired miRNA genes processing. The presence of the RAN gene polymorphism (rs 14035) may increase the risk of recurrent miscarriages. RAN gene is a member of the "large family of RAS" and is a small essential GTPase for the translocation of RNA and proteins through the nuclear pore. It is also involved in mitosis as well as DNA synthesis and promoting the cell cycle. Mutation in the RAN gene, which encodes the RAN-producing gene, disrupts DNA synthesis and can play a crucial role in abortion (3, 4). Previous studies showed the effect of genetic changes on inducing RPL as a major pregnancy complication. However, there are still so many controversies around these cause and effect (5-9).
miRNAs regulate gene expression at the post-transcriptional stage by suppressing translation or mRNA reduction (10). About 30% of human genes are the targets of protected miRNAs, hence showing that miRNAs are the key regulators in many biological pathways (11). Previous studies have shown a significant relationship between recurrent miscarriage and rs 14035 in women with RPL (12-14).
Since the polymorphism of a gene may be not the same in different populations and geographical areas, this study aimed to determine the frequency and relationship of rs 14035 with RPL in women referred to Yazd Reproductive Sciences Institute.
2. Materials and Methods
In this case-control study, blood samples from 100 women aged 20-40 yr with at least two or more idiopathic miscarriages were collected. All cases were referred to the Yazd Reproductive Sciences Institute between March and December 2018.
The control group (n = 100) consisted of 20-40 yr-old women with no history of abortion and having at least one successful pregnancy and normal delivery.
All women with cytogenetic problems, anatomical abnormalities in the reproductive tract, immunological disease, hormonal abnormalities (including thyroid and prolactin disorders), infection, history of cancer, and spouses with abnormal karyotype or impaired semen analysis were excluded.
3. DNA extraction
A total of 200 DNA samples extracted from 2 μl blood specimens from the case and control groups were studied. As previously reported "RNA was isolated from blood samples using the QuantiTectR, RNeasy Micro kit (Qiagen Europe, Germany) according to the manufacturer's instructions. The RNA concentration was measured by NanoDrop spectrophotometer and adjusted to a concentration of 1000 ng/μl. Then, cDNA was synthesized by a RevertAid First Strand cDNA synthesis kit (Thermo Fisher Scientific Inc.), according to the manufacturer's guides. The reverse transcription was performed in 20 μl reactions for 60 min at 42ºC, followed by 70ºC for 5 min to put the reverse transcriptase out of action. The products of reverse transcription reaction were straightly used in polymerase chain reaction (PCR) in a separate step to amplify the targets (15)".
4. Polymerase chain reaction
The final volume of PCR reactions was assumed to be 25 µl in this study so that the mastermix (12.5 µl), DNA (3 µl), forward primers (1 µl), reverse primers (1 µl), and water (7.5 µl) can reach to a volume of 25 µl. It was then mixed in 0.2 microtubes and placed in a thermocycler followed by vortex and microfusion, and based on the temperature program given to the device, the given parts were reproduced. When the PCR reaction was completed, we used electrophoresis to confirm the PCR product and to ensure that it was not contaminated. The microtubes were removed from the apparatus, and 5 µl of the reaction product plated on 2% agarose gel was sampled and subjected to 95 V for 1 hr. The agarose gels were then photographed and analyzed by gel docking. Electrophoresis results were single band in the 152 bp region without any specific band. After completing the samples and examining the products by electrophoresis and ensuring the specific amplification of the PCR product fragment for subsequent steps, it was stored at -20ºC. PCR was performed again if the samples lacked bands or had poor bands.
After performing PCR reaction for all the patients and controls, the final study was performed by PCR-RFLP (Restriction fragment length polymorphism) technique using BSL1-restricting enzyme. Following the optimization of enzymatic digestion conditions, all samples were subjected to this enzyme and then plated on 2% agarose gel. The optimal temperature for enzymatic digestion of PCR products by the BSL1 enzyme is 55ºC. The PCR-RFLP procedure was performed as follows: 18 µl of water was poured into a microtube and then 2 µl of enzyme buffer and 1 µl of enzyme were added. Next, 10 µl of PCR product was added and vertex was performed. The specimens were then incubated in the incubator for 3 hr at 55ºC. Finally, 10 µl of the reaction product was applied to 2% agarose gel and exposed to 100 V for 1 hr in order to test the product and then placed in a dock gel to see the result of the gel test (Figure 1).
In the present study, regarding the enzymatic fragmentation status (CCNNNNNNNGG), by conducting PCR-RFLP technique using BSL1 enzyme and performing gel electrophoresis of reaction products, we expected to observe three different patterns as follows:
In the single-band 152 observation mode after enzymatic digestion, we have the TT allele.
In the two-bands (127 + 25) observation mode, we have CC allele.
In the three-bands (252 + 127 + 25) observation mode, we have CT allele.
2.3. Ethical consideration
The research proposal was approved by the Ethics Committee of Yazd Reproductive Sciences Institute, Yazd, Iran (Code: IR.SSU.RSI.REC.1397.024). All participants' information was extracted from their hospital records maintaining confidentiality and entered into the study data collection form.
2.4.Statistical analysis
SPSS software (Statistical Package for the Social Sciences, version 20.0, SPSS Inc, Chicago, Illinois, USA) was used for statistical analysis. Statistical comparisons were performed by Chi-Square and Students' t tests. P-value < 0.05 was considered as statistically significant.
3. Results
In this study, DNA were extracted from 200 peripheral blood (n = 100/each group). The mean age of the samples in the case and control group were 28.57 ± 4.76, and 27.67 ± 4.09 yr, respectively (p = 0.16). The residential place of case group were 31% from Yazd (n = 31) and 69% (n = 69) was elsewhere (outside the province) (p < 0.001). All of the participants in the control group were from Yazd province (100%).
In the case group, 73 (73%) had a history of abortion in the first trimester of pregnancy, 8 (8%) in the second and third trimesters of pregnancy, and 19 (19%) had a history of abortion in all trimesters. Only 7 (7%) had a history of ectopic pregnancy. Moreover, 9% had a history of stillbirth, 23% a history of partial hydatidiform mole, 25% primary infertility, and 9% had the secondary infertility. In addition, 41% of the couples in the case group had consanguinity and 59% had no consanguineous marriage. There was no significant difference between the genotypic frequency of rs14035 polymorphism in the three CC, CT, and TT genotypes in the case and control groups (p = 0.882) (Table I).
Allele C frequency was 142 (71%) in the women with recurrent miscarriages and 140 (70%) in the control group. The number of allele T in the case group was 58 (29%) and in the control group 60 (30%). Statistical comparison showed no significant difference between the frequency of alleles C and T and the polymorphism studied in the case and control participants (Odds ratio: 0.953; CI: 0.620-1.465; p = 0.826).
The frequency of abortion in the case group (n=100) was as follows: 73 women (73%) had a history of miscarriage in the first trimester, 8 (8%) had a history of miscarriage in second and third trimesters and 19 (19%) had a history of both types of miscarriage. Statistical analysis using the Chi-square test did not show a significant relationship between abortion time and genotype in our participants (p = 0.528) (Table II).
According to the results, no significant relationship was identified between abortion time, history of stillbirth, ectopic pregnancy, and frequency of hydatidiform mole pregnancy with genotypes of the participants (p = 0.528, p = 0.905, p = 0.688, and p = 0.738, respectively) (Table III).
Rights and permissions | |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |